Pharmacokinetic Evaluation of Empagliflozin
NCT03059056
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
Empagliflozin 25mg
Sponsor
British University In Egypt